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Objective: To evaluate perioperative results and long term survival in patients with severe left ventricu-
lar (LV) dysfunction undergoing coronary artery bypass grafting (CABG) using non-cardioplegic meth-
ods.
Methods: From April 1990 through December 1999, 4100 consecutive patients underwent isolated
CABG using hypothermic ventricular fibrillation. Of these, 141 (3.4%) had severe LV dysfunction (ejec-
tion fraction < 30%). Mean age was 58.3 (9.6) years. 64 patients (45.4%) were in Canadian Cardio-
vascular Society class III or IV and 16 (11.3%) were subjected to urgent or emergent surgery. A
previous myocardial infarction was recorded in 127 (90.1%). The majority (89.4%) had triple vessel
and 26 (18.4%) had left main disease. The mean number of grafts per patient was 3.1. At least one
internal thoracic artery was used in all patients and 21 (14.8%) had bilateral internal thoracic artery
grafts (1.2 arterial grafts per patient).
Results: Perioperative mortality was 2.8% (4 patients) and the incidence of acute myocardial infarc-
tion 2.8%. 50 (35.5%) patients required inotropes but only 16 (11.3%) required it for longer than 24
hours; 5 patients (3.5%) needed mechanical support. The incidence of renal failure was 3.5%. Mean
duration of hospital stay was 9.6 (8.3) days. Follow up was 95% complete and extended for a mean
of 57 (30) months. Late mortality was 11.5%. Actuarial survival rates at 1, 3, and 5 years were 96%,
91%, and 86%, respectively.
Conclusions: Non-cardioplegic techniques are safe and effective in preserving the myocardium dur-
ing CABG in patients with coronary artery disease and poor LV function, with low operative mortality
and morbidity, and encouraging medium to long term survival rates.
Coronary artery bypass grafting (CABG) in patients withadvanced left ventricular (LV) dysfunction has beenregarded as a high risk procedure.1 2 However, because
alternative surgical treatments (such as transplantation and
cardiomyoplasty) have considerable limitations and the
results of medical treatment are often unsatisfactory, revascu-
larisation should always be considered as a treatment
option.3 4 In addition, advances in surgical technique, peri-
operative care, and myocardial protection have enhanced the
safety of CABG in this cohort of patients.5–9
Effective myocardial preservation is essential for successful
CABG when the myocardium is handicapped. However, there
is still controversy over the optimal technique of myocardial
protection and a variety of safe and effective methods, which
involve the use of either crystalloid or blood cardioplegia, are
available and routinely used by most surgeons. Nonetheless,
non-cardioplegic methods have gained in popularity. For the
past 10 years, we have routinely opted to perform CABG under
hypothermic ventricular fibrillation. The present study was
undertaken to assess the results achieved by this approach in
patients with severe LV dysfunction.
PATIENTS AND METHODS
Demographic, clinical, operative, perioperative, and in-
hospital outcome data were collected prospectively and
entered into a computerised database comprising all patients
undergoing CABG at our institution. From this database, the
records of 4100 patients undergoing isolated CABG with non-
cardioplegic methods between April 1990 and December 1999
were retrieved for analysis. Data for 141 (3.4%) patients
(group 1) with severe impairment of LV function (ejection
fraction (EF) < 30%), determined semiquantitatively by
contrast ventriculography, were analysed. Echocardiography
and nuclear ventriculography were carried out in a minority of
patients and, when these additional data were available, the
highest EF value was used for subsequent analysis. All
patients had angina or evidence of ischaemia.
Patients
Table 1 details the perioperative clinical and angiographic
data. The mean age of the 133 male (94.3%) and eight female
patients was 58.3 (9.6) years. Forty (28.6%) patients had
diabetes and 72 (51.1%) had dyslipidaemia. Sixty four (45.4%)
were in Canadian Cardiovascular Society class III or IV. Twelve
(8.5%) patients had been on intravenous antianginal medi-
cation in the last two days before the operation (unstable
angina). A previous myocardial infarction was recorded in 127
patients (90.1%), 11 (7.8%) of which had occurred in the 30
days preceding coronary surgery. The majority (88.7%) of the
patients were operated on electively.
One hundred and twenty six patients (89.4%) had triple
and 14 (9.9%) had double vessel coronary disease. Twenty six
(18.4%) had left main disease. There was only one case of
repeat CABG among these patients. By definition, the EF was
< 30% in all cases (range 12–29%).
Surgical technique and operative data
Cardiopulmonary bypass was instituted using a bubble or
membrane oxygenator and non-pulsatile flow. Patients were
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cooled to an oesophageal temperature of 30–32°C. An LV vent
was always placed through the right superior pulmonary vein
and left atrium. No topical cooling was used.
The method predominantly used during the construction of
the distal anastomoses was ventricular fibrillation, without
clamping of the aorta. This method has been described in
detail in a previous report, and we refer here to only some
aspects.8
Generally, the anastomoses to the right coronary artery or
its branches on the inferior surface of the heart were
constructed first, followed by the anastomoses to the branches
of the circumflex system. Bypasses to the anterior descending
artery and its diagonal branches were performed last. Very
early in the series, the proximal anastomoses of each vein graft
was usually constructed immediately after the distal one, but
now all distal anastomoses are constructed first, followed by
all proximal anastomoses in a single partial clamping period.
In the case of ongoing ischaemia, the coronary artery branch
that was likely to be involved was grafted first followed imme-
diately by the proximal anastomosis. Control of residual and
collateral blood flow was achieved by a variety of methods,
mainly with the use of the coronary occluders and a gentle jet
of oxygen.
Internal thoracic artery (ITA) grafts were used in all
patients. In 21 (14.8 %) patients both left and right ITAs were
used, for a mean of 1.2 (0.4) arterial anastomoses per patient.
Additionally, a mean of 1.9 (0.8) venous anastomoses were
constructed per patient. Hence, an average of 3.1 (0.7) coron-
ary artery branches were bypassed per patient. Endarterecto-
mies were performed in 26 cases (18.4 %), 19 of the right cor-
onary and seven of the left system. Perfusion time was 69.4
(20.2) minutes.
Statistical methods
Data were collected prospectively on standard forms and
entered into a computerised database. All data were retrospec-
tively analysed with the assistance of Systat statistical
software (Systat Software Inc). All data are expressed as mean
(SD) or as proportions. For univariate analysis of categorical
data, the χ2 test (2 × 2 contingency tables) or Fisher’s exact
test were used. Univariate analysis of continuous variables
was carried out using Student’s t test. Long term actuarial
survival rates were calculated using the Kaplan-Meier
method.
RESULTS
There were four (2.8%) perioperative deaths (defined as
deaths in the hospital or within 30 days if the patient was dis-
charged sooner). Three patients died of cardiac failure and one
of respiratory failure. Fifty patients (35.5%) required inotropic
support (defined as the use of any inotropic agent after the
patient left the operating room) but only 16 (11.3%) for peri-
ods longer than 24 hours. Mechanical support (intra-aortic
balloon or LV assist device) was used in five patients (3.5%).
Five patients (3.5%) developed acute renal failure (creatinine
> 220 µmol/l) but none required dialysis. Four patients (2.8%)
had ECG criteria of perioperative myocardial infarction.
Supraventricular arrhythmias necessitating medical or electri-
cal treatment occurred in 24 patients (17.0%). Three patients
(2.1%) had an episode of ventricular fibrillation, successfully
converted, and another three had transient complete atrioven-
tricular block. Three patients (2.1%) required re-exploration
because of haemorrhage and seven (4.9%) were reoperated for
sternal dehiscence, including three with the diagnosis of acute
mediastinitis (presence of pus or bacterial growth in the
mediastinal tissues sampled during surgical re-exploration).
Five patients (3.5%) had a cerebrovascular accident, all with at
least partial recovery. The mean length of hospital stay was 9.6
(8.3) days.
Follow up was conducted by mail or telephone and was 95%
complete. The mean follow up time of the 130 survivors (seven
patients were lost) was 57 (30) months (range 9–124
months). Fifteen patients (11.5%) had died. The actuarial sur-
vival at one, three, and five years was 96%, 91%, and 86%,
respectively (fig 1).
To place the immediate results into perspective, results for
group 1 were compared with the clinical, angiographic, and
operative data, as well as of the mortality and in-hospital
events, of 3557 patients with normal LV function or only mild
dysfunction (EF > 40%) who had undergone isolated CABG
during the same time period (group 2; tables 2 and 3).
Compared with group 2 patients, those in group 1 were
younger and had higher incidences of peripheral vascular dis-
ease, anaemia, cardiomegaly, and prior myocardial infarction.
There were no significant differences in the angina symptoms
or in the preoperative use of intra-aortic balloon pump.
On the other hand, patients with severe LV dysfunction had
more extensive coronary artery disease (mean number of ves-
sels involved was 2.9 v 2.7 in group 2; p < 0.001). This differ-
ence results essentially from a larger number of patients with
single vessel disease in group 2. Hence, as would be expected,
Table 1 Preoperative clinical data in 141 patients
with left ventricular dysfunction
Number
Mean age (years) 58.3 (9.6)
Sex (male) 133 (94.3%)
Coronary risk factors
Diabetes mellitus 40 (28.6%)
Smoking 92 (65.2%)
Hypertension 70 (49.6%)
Dyslipidaemia 72 (52.2%)
Family history of CAD 33 (23.6%)
History of MI
Old 116 (82.3%)
Recent (<30 days) 11 (7.8%)
Peripheral vascular disease 22 (15.6%)
Cerebrovascular disease 5 (3.5%)
Angina (CCS class)
I 14 (9.9%)
II 63 (44.7%)
III 46 (32.6%)
IV 18 (12.8%)
Unstable angina 12 (8.5%)
Cardiomegaly 64 (45.4%)
Anaemia 10 (7.1%)
Extent of disease
One vessel 1 (0.7%)
Two vessels 14 (9.9%)
Three vessels 126 (89.4%)
Left main disease 26 (18.4%)
LVEDP >20 mm Hg 107 (75.8%)
Prior IABP support 1 (0.7%)
CAD, coronary artery disease; CCS, Canadian Cardiovascular
Society; IABP, intra-aortic balloon pump; LVEDP, left ventricular end
diastolic pressure; MI, myocardial infarction.
Figure 1 Kaplan-Meier survival curve of the 141 patients in the
study.
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there was a significant difference in the number of coronary
artery grafts constructed per patient (3.2 v 2.8, respectively;
p < 0.0001). The mean number of arterial grafts per patient
was similar in the two groups.
Mortality was higher in group 1 (2.8%) than in group 2
(0.9%; p = 0.025). The use of inotropes or mechanical support
and the number of sternal complications were also higher in
group 1. There were no significant differences in the
incidences of myocardial infarction, stroke, acute renal failure,
arrhythmias, and reoperation for bleeding. Finally, patients in
group 1 had a longer hospital stay (1.7 days longer; p = 0.002)
but there was no difference if only survivors were counted.
DISCUSSION
Patients with coronary disease and advanced LV dysfunction
have a poor prognosis when treated only medically. They have
a limited survival and usually die of cardiac causes. On the
other hand, several studies have shown that they respond bet-
ter to coronary surgery.1 2 4 10 Although transplantation is an
effective treatment option, it is limited by availability of donor
organs and by the implications of immunosuppression. There-
fore, revascularisation should always be considered as an
option in these patients. It has been shown that CABG
increases survival, improves functional status, provides better
control of angina symptoms, and reduces the prevalence of
sudden cardiac death caused by arrhythmias.1 3 4 7 9 11
Case selection and myocardial protection
One important question to be addressed is which patients
with severe coronary artery disease and low EF would derive
most benefit. It has been suggested that symptoms of angina
(versus symptoms of heart failure) are associated with a more
favourable outcome.12 Some groups require evidence of
reversible ischaemia or viability of hibernating myocardium by
radioisotopic scanning, positron emission tomography, or
dobutamine echocardiography to select patients for this
approach.13 14 We have not excluded patients because of lack of
significant angina, nor have we routinely used viability studies
to select candidates for grafting. Patients were considered to
be unsuitable for grafting only if they had angiographic
evidence of diffuse distal disease, particularly of the anterior
descending artery, or in the presence of comorbidities that
significantly increase operative risk.
We concur with others in that, in patients with little
functional reserve, favourable results can only be achieved
Table 2 Comparison of clinical and operative data between groups 1 and 2
Variable Group 1 Group 2 p Value
Number of patients 141 3557
Mean age (years) 58.3 (9.6) 60.1 (9.2) 0.032
Sex (female) (%) 5.7 11.7 0.027
Coronary risk factors (%)
Diabetes mellitus 28.6 20.3 0.017
Smoking 65.2 53.9 0.008
Hypertension 49.6 56.9 NS
Dyslipidaemia 52.2 55.5 NS
Family history of CAD 23.6 22.2 NS
History of MI (%)
Old 82.3 45.1 <0.001
Recent (<30 days) 7.8 4.9 NS
Peripheral vascular disease (%) 15.6 11.1 0.023
Cerebrovascular disease (%) 3.5 4.8 NS
Angina (CCS class III/IV) 46.1 42.0 NS
Cardiomegaly (%) 45.4 7.9 <0.001
Anaemia (%) 7.1 4.2 0.042
Number of diseased vessels (mean) 2.9 (0.3) 2.7 (0.6) <0.001
Left main disease (%) 18.4 15.8 NS
Surgical priority (elective) (%) 89.3 92.1 NS
Number of grafts/patient (mean) 3.1 (0.7) 2.8 (0.8) <0.001
Number of arterial grafts/patient (mean) 1.2 (0.5) 1.3 (0.5) NS
Number of venous grafts/patient (mean) 1.9 (0.8) 1.5 (0.8) <0.001
Arterial conduits (%)
LITA 100.0 99.2 NS
RITA 14.8 24.1 <0.001
Endarterectomy (%) 18.4 9.2 <0.001
Perfusion time (min) (mean) 69.4 (20.2) 6 3.2 (26.0) <0.001
LITA, left internal mammary artery; RITA, right internal mammary artery.
Table 3 Comparison of results (%) between groups 1 and 2
Variable Group 1 Group 2 p Value
Mortality 2.8 0.9 0.025
Morbidity
Inotropic support 35.5 5.5 <0.001
Mechanical support 3.5 0.6 <0.001
Perioperative MI 2.8 4.1 NS
Acute renal failure 3.5 2.8 NS
Reoperation for bleeding 2.1 2.5 NS
Reoperation for sternal complications 4.9 2.1 0.022
Stroke 3.5 2.1 NS
Arrhythmias 19.1 23.3 NS
Hospital stay (mean time in days) 9.6(8.3) 7.9(5.6) 0.002
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with optimal myocardial protection. An unending series of
reports dealing with cardioplegia in any of its numerous vari-
ations have shown this unequivocally. However, this evidence
does not mean that non-cardioplegic methods result in less
protection. In fact, several randomised clinical studies have
shown that intermittent aortic cross clamping provides
protection that is equivalent to, if not better than, blood
cardioplegia and preserves LV diastolic function better.15–18 We
and others have previously shown the safety and efficacy of
these methods, even in higher risk patients, possibly because
during the operation the myocardium is continuously
perfused with the patient’s unaltered blood.8 19–21
The use of off-pump coronary bypass in this subgroup of
patients has recently been studied with respect to early
outcomes. Two recent retrospective studies have reported
similar results when comparing off-pump coronary bypass
with cardioplegic techniques and concluded that this method
is safe and efficacious.22 23 The question may also be raised
about non-cardioplegic methods. Nonetheless, anatomical
factors, which were frequently found in our patients, such as
cardiomegaly and, more important, heavily calcified vessels
requiring endarterectomy, may preclude off-pump coronary
bypass in many of these patients. We believe that longer follow
up is required before a conclusion can be reached.
Perioperative results and survival
Recent reports indicate that the perioperative mortality after
CABG in patients with advanced LV dysfunction varies
between 2.5–8%.5–8 In the present series, the perioperative
mortality was 2.8%. As others have experienced, we have had
a higher requirement for inotropic support than in our
patients with an EF > 40%. However, in contrast with other
studies, in our study very few patients (3.5%) required
mechanical support in the early postoperative period, and the
incidence of myocardial infarction was 2.8%.5 9 12 Considering
the characteristics of the group, these results are quite accept-
able and compare favourably with those of series where
cardioplegic methods were used. The relatively low incidence
of other causes of morbidity and the short hospital stay also
constitute good clinical benchmarks for a relatively smooth
perioperative period.
However, the incidence of sternal complications was some-
what higher (4.9%) than those reported by others, which may
be related to the fact that all of our patients received ITA
grafts, including 14.8% in whom both ITAs were used.6 The use
of ITA grafts in this cohort of patients is an important issue
because the reports are conflicting. Concerns about the short
term limitations of ITA grafts may have made surgeons more
likely to use venous conduits in these high risk patients. Even-
tual problems of the ITA include lower initial flow than with
vein grafts, the potential for spasm, the time required for har-
vesting in unstable patients, and, eventually, the inability to
deliver the cardioplegic solution down a pedicled arterial
graft. Additionally, the reduced late survival usually associated
with LV dysfunction, advanced age, and significant co-
morbidities in these patients may offset the survival advan-
tage generally associated with ITA use.
Despite these concerns, we follow a more liberal approach.
We used left ITA grafts in all patients of the study group and,
additionally, right ITA grafts in 21 (14.8%) patients. Some
similar studies reported left ITA use in 76–86% of patients
with LV dysfunction, with excellent initial results.7 11 Anderson
and colleagues24 reported the use of left ITA in 70% of patients
with ventricular dysfunction presenting with chronic conges-
tive heart failure and concluded that its use enhanced late
survival. By contrast, others have used ITA in as few as 41% of
patients, and some question the survival benefit of the use of
the left ITA conduit in these patients.25 26 In any case, early
outcomes have not been adversely affected by the use of arte-
rial grafts in the setting of ventricular dysfunction.
In a previous publication, we had already shown this
favourable immediate outcome. Apart from increasing the
number of patients studied, we have now been able to
complete the medium term follow up (mean 57 (30)
months).8 Our five year survival of 86% compares favourably
with those reported by others after CABG in patients with
severe LV dysfunction of between 60–80%.7 9 11 27–29 However, it
is important to note that some of these studies included only
patients with an EF of< 20%. Another possible reason for this
difference may be related to our population being somewhat
younger and with fewer female patients, which are two
important clinical factors positively correlated with early and
late death. Compared with the dismal outcome generally
observed with medical treatment alone, these survival rates
have to be considered excellent.
The present study has some limitations. These include the
definition of severe LV dysfunction as EF of < 30% determined
semiquantitatively by contrast ventriculography, which is not
very precise. In fact, assessing ventricular function on contrast
ventriculography is not entirely satisfactory. In some cases this
study was done after the coronary arteriogram, which could
have overestimated the incidence of LV dysfunction. However,
in many cases where there was doubt, other methods of indi-
rect measurement of the EF helped to clarify the situation.
Additionally, because the long term survival results in the
group with EF> 40% are not available yet, it is not possible to
put into perspective these results by comparison with those
here reported for patients with ventricular dysfunction.
Finally, although some of the significant differences found
between groups 1 and 2 may have little clinical relevance, it is
quite evident that the higher incidence of diabetes and the
more extensive vessel disease, requiring a higher number of
grafts, may have had an impact in the early and long term
results.
In conclusion, the results reported herein confirm that
non-cardioplegic techniques are safe and effective in preserv-
ing the myocardium during CABG, including in patients with
poor LV function, in whom low operative mortality and
morbidity rates were achieved. This study also confirmed an
encouraging medium to long term survival in this high risk
population.
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Successful radiofrequency catheter ablation of “clockwise”
and “counterclockwise” bundle branch re-entrant
ventricular tachycardia in the absence of myocardial or
valvar dysfunction without detecting bundle branch
potentials
K Matsuoka, E Fujii, F Uchida
A case is reported of a patient with only isolated conduction
abnormalities of the His-Purkinje system with no identifiable
myocardial or valvar dysfunction, leading to “clockwise” and
“counterclockwise” bundle branch re-entrant ventricular
tachycardias (BBRVTs). The electrophysiological study
showed infra-Hisian conduction system disease and two
different inducible wide QRS complex tachycardias. Neither
right bundle branch nor left bundle branch potentials were
recorded despite extensive catheter manipulation. However,
these tachycardias were diagnosed as BBRVTs by using
entrainment manoeuvres and comparing the HV intervals
during both sinus rhythm and the tachycardias. These tachy-
cardias were eliminated by catheter ablation of the right bun-
dle branch, using the morphology of the local electrograms
and anatomical findings.
(Heart 2003;89:e12) www.heartjnl.com/cgi/content/full/89/
4/e12
Concordance for hypoplastic left heart syndrome in a
monochorionic twin pregnancy
R E Andrews, A C Cook, R W M Yates
The risk of structural heart disease is significantly higher in
twin pregnancies than in singleton pregnancies, but the con-
cordance rate has been found to be relatively low, even in
monochorionic pregnancies. This is the first report of a mono-
chorionic twin pregnancy concordant for hypoplastic left
heart syndrome (HLHS), the diagnosis having been made by
fetal echocardiography at 15 weeks’ gestation. The findings
were confirmed at necropsy at 17 weeks’ gestation, following
termination of pregnancy. Both twins had mitral and aortic
atresia, with severely hypoplastic aortic arches. This report
adds weight to there being a genetic component to the cause
of HLHS in some cases and illustrates how the findings from
early fetal echocardiography with postmortem follow up can
help to extend the understanding of the aetiology of this con-
dition.
(Heart 2003;89:e13) www.heartjnl.com/cgi/content/full/89/
4/e13
Toad venom poisoning: resemblance to digoxin toxicity
and therapeutic implications
R M Gowda, R A Cohen, I A Khan
A healthy man developed gastrointestinal symptoms after
ingesting purported aphrodisiac pills. He had severe unrelent-
ing bradycardia, hyperkalaemia, and acidosis. He rapidly
developed severe life threatening cardiac arrhythmias and
died after a few hours. He was found to have positive serum
digoxin concentrations, although he was not taking digoxin.
Toad venom poisoning is similar to digitalis toxicity and
carries a high mortality. Cardiac glycoside poisoning can occur
from ingestion of various plants and animal toxins, and the
venom gland of cane toad (Bufo marinus) contains large quan-
tities of cardiac glycosides. Toad venom, a constituent of an
aphrodisiac, was considered responsible for the development
of clinical manifestations and death in this patient. Digoxin
specific Fab fragment has been reported to be beneficial in the
treatment of toad venom poisoning. This report alerts
physicians to the need to be aware of a new community toxic
exposure, as prompt treatment with digoxin specific Fab frag-
ment may be life saving. The treatment approach to patients
with suspected toad venom poisoning is described
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